A new promising risk stratifying tool based on combination of lymphovascular invasion and systemic immune-inflammation index to predict the survival and to help evaluate the potential benefit of adjuvant chemotherapy for upper tract urothelial carcinoma

• H-C. Jan,
• C-Y. Hu,
• W-H. Yang,
• C-H. Ou

Affiliations

H-C. Jan

C-Y. Hu

W-H. Yang

C-H. Ou